Amgen has inaugurated its new technology and innovation center in Hyderabad, marking a significant milestone in its global expansion. The company plans to invest $200 million by 2025, with additional investments anticipated in the coming years. This facility will bolster Amgen’s digital capabilities, leveraging artificial intelligence and data science to advance its pipeline of medicines while creating opportunities for local talent.

Located in HITEC City, the Hyderabad site spans approximately 524,000 square feet across RMZ Tower 110 of Spire and Tower 20 of Nexity. The inauguration was attended by Amgen Chairman and CEO Robert A. Bradway, along with Telangana Chief Minister Anumula Revanth Reddy and Minister D. Sridhar Babu.

Bradway highlighted that Amgen India will play a crucial role in advancing innovation by integrating technology and life sciences to strengthen Amgen’s digital infrastructure worldwide. Som Chattopadhyay, Amgen India’s national executive, emphasized the company's commitment to contributing to the global biotech landscape, while Managing Director Naveen Gullapalli noted Hyderabad’s strategic position as a growing technology hub.

With nearly 28,000 employees across 100 countries, Amgen’s investment in Hyderabad reinforces its commitment to technological innovation and global healthcare advancements. The collaboration with Telangana’s government is expected to further strengthen the city’s position as a leading biotech and technology hub.